Navigation Links
Nuvasive Reports Third Quarter 2008 Financial Results
Date:10/22/2008

2008 2007

Assets

Current assets:

Cash and cash equivalents $104,388 $61,915

Short-term investments 72,157 19,247

Accounts receivable, net 46,072 27,496

Inventory, net 58,418 36,280

Prepaid expenses and other current assets 3,352 1,240

Total current assets 284,387 146,178

Property and equipment, net of

accumulated depreciation 73,159 43,538

Intangible assets, net of accumulated

amortization 57,041 24,496

Long-term marketable securities 45,148 8,536

Other assets 8,892 2,939

Total assets $468,627 $225,687

Liabilities and Stockholders' Equity

Current liabilities:

Accounts payable and accrued liabilities $20,078 $13,839

Accrued payroll and related expenses 13,853 12,075

Royalties payable 2,310 2,076

Total current liabilities 36,241 27,990

Senior convertible notes 230,000 -

Long-term liabilities 27,226 1,119

Commitments and contingencies

Stockholders' equity:

Common stock 36 35

Additional paid-in capital 374,695 364,469

Accumulated other comprehensive income

(loss) (363) 54

Accumulated deficit (1
'/>"/>

SOURCE NuVasive, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. NuVasive to Present at Morgan Stanley Global Healthcare Unplugged Conference
2. NuVasive Completes Acquisition of Osteocel Biologics Business
3. NuVasive Announces Web Cast and Conference Call of Second Quarter 2008 Results
4. NuVasive to Present at William Blair 28th Annual Growth Stock Conference
5. NuVasive Signs Definitive Agreement to Acquire Osteocel Biologics Business from Osiris Therapeutics
6. NuVasive to Present at Lehman Brothers Eleventh Annual Global Healthcare Conference
7. NuVasive to Present at Canaccord Adams Small-Cap Orthopedics Conference
8. NuVasive Announces Webcast and Conference Call of Fourth Quarter and Full Year 2007 Results
9. NuVasive to Host Investor Reception on September 11, 2007
10. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
11. Sangui Biotech International, Inc., Reports Sales Decrease, Continued Losses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... BlueInGreen, LLC ( BlueInGreen® ) and ... PCI, Inc., leading suppliers of ozone process technology ... to provide a new state-of-the-art ozone system for ... Wastewater Treatment. The new ozone disinfection system ... dissolution technology, Pinnacle Ozone’s industry leading Zenith™ ozone ...
(Date:11/21/2014)... 2014 2014 Deep Research Report ... in-depth research report on the transformer market. The ... application, and industry chain structure as well as ... analysis, including China’s domestic market as well as ... situation analysis. The report also covers information on ...
(Date:11/21/2014)... SAN DIEGO , Nov. 20, 2014  Cytori Therapeutics ... Marc Hedrick , M.D. will present live at VirtualInvestorConferences.com ... 4, 2014 TIME:    11:15 am PT / 2:15 ... this URL into your browser,s address bar: http://bit.ly/1B2KGaL ... time and receive event updates. This will ...
(Date:11/18/2014)... Sarasota, FL (PRWEB) November 17, 2014 ... novel point-of-care diagnostic tests – today announces its ... Control and Prevention’s (CDC) Get Smart About Antibiotics ... Antibiotics Week is a national campaign designed to ... local health departments, and non-profit and for-profit partners ...
Breaking Biology Technology:City of Fayetteville Leads Nation with Innovative Ozone Technology 2City of Fayetteville Leads Nation with Innovative Ozone Technology 3City of Fayetteville Leads Nation with Innovative Ozone Technology 4International Transformer Industry - Analysis on Applications, Development & Forecasts Now Available at ReportsnReports.com 2International Transformer Industry - Analysis on Applications, Development & Forecasts Now Available at ReportsnReports.com 3Cytori Therapeutics to Provide Corporate Update and Investor Presentation on December 4 through a Live, Interactive Webcast 2Cytori Therapeutics to Provide Corporate Update and Investor Presentation on December 4 through a Live, Interactive Webcast 3Cytori Therapeutics to Provide Corporate Update and Investor Presentation on December 4 through a Live, Interactive Webcast 4RPS Again Partners with the CDC in Support of the 2014 Get Smart About Antibiotics Week 2RPS Again Partners with the CDC in Support of the 2014 Get Smart About Antibiotics Week 3
... Calif., June 3, 2011 Masimo (NASDAQ: MASI ) ... William Blair & Company 31st Annual Growth Stock Conference at the ... a.m. Central Time.  A live audiocast of the presentation will be ... of the audiocast will be available following the live presentation. ...
... HOUSTON, June 2, 2011 Working to better predict ... biologist and his team have discovered some surprising things ... possible to predict the progression of chronic disease. ... describe their findings in a paper titled "Negative Epistasis ...
... Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH ... shares of its common stock in an underwritten public offering. ... to purchase up to an additional 15% of the shares ... over-allotments, if any.  Citi and Leerink Swann LLC are acting ...
Cached Biology Technology:Masimo to Present at William Blair & Company 31st Annual Growth Stock Conference 2Work by UH evolutionary biologist may one day help with chronic diseases 2Anthera Pharmaceuticals Announces Proposed Public Offering of Common Stock 2Anthera Pharmaceuticals Announces Proposed Public Offering of Common Stock 3
(Date:11/7/2014)... Nov. 7, 2014  In conjunction with the ... Departments, The Community Foundation of the Verdugos has announced the ... JUSTICE PROJECT," a $250,000 initiative to keep the Verdugo Regional ... its first six months of existence, the Lab has processed ... for local law enforcement. "Because our number one ...
(Date:11/6/2014)... 6, 2014 - Insilico Medicine, Inc, a Baltimore-based ... age related diseases announced a research collaboration with ... Champions Oncology, Inc (OTC: CSBR). , "There are ... medicine, but Champions Oncology,s TumorGraft technology is unique ... chemotherapy regimen experimentally generating vast amounts of valuable ...
(Date:11/4/2014)... right amount of death at the right time might ... new research that could help in understanding animal populations, ... In a paper in the journal Trends in ... European colleagues conclude that the kind of positive population ... individuals, or mortality, depends on the size and developmental ...
Breaking Biology News(10 mins):Community Foundation Of The Verdugos Unveils Campaign To Fund Glendale-Burbank DNA Justice Project 2Insilico Medicine, Inc announces research collaboration with Champions Oncology, Inc 2When less is more: Death in moderation boosts population density in nature 2
... have found that humans aren,t the only ones who can ... too. This capability was previously believed to be specific to ... mimic sound seem to be able to keep a beat, ... study was led by Adena Schachner, a doctoral candidate in ...
... Following a successful second funding period, the first three ... continue for another four years. This decision was made ... German Research Foundation) at its spring session in Bonn. ... Ocean in the Earth System" in Bremen, "The Center ...
... the spring allergy season, things are looking up. A research ... Journal of Leukocyte Biology ( http://www.jleukbio.org ) shows how ... cellular switch that turns allergies and asthma both on and ... for some people with asthma and allergies, their problems might ...
Cached Biology News:Some vocal-mimicking animals, particularly parrots, can move to a musical beat 2Some vocal-mimicking animals, particularly parrots, can move to a musical beat 3The first DFG research centers to be funded for another four years 2The first DFG research centers to be funded for another four years 3The first DFG research centers to be funded for another four years 4Just in time for spring: Scientists find the cellular on and off switch for allergies and asthma 2
IHC Polymer Detection Kit (Rabbit DAB)150 slides...
... Desselberger (1995) • This book is ... classical and molecular techniques currently used ... and analysis of virus-specific antibodies and ... presented covering immunoassays, blotting and hybridization ...
Performance, mycoplasma, virus, and endotoxin tested. Collected from calves 14 days old or less...
Bovine Serum...
Biology Products: